Orbital Inflammatory Pseudotumor following mRNA COVID-19 Vaccination
The authors present a case of orbital pseudotumor after mRNA COVID-19 vaccination. A 40-year-old otherwise healthy woman was referred to our oculoplastics unit because of left blepharoptosis of 2 months duration starting 1 week after she received her first Pfizer-BioNTech mRNA vaccination. On presentation, her best-corrected visual acuity was 20/20 in each eye. The external examination revealed left blepharoptosis and mild upper eyelid swelling. Orbital magnetic resonance imaging revealed left lacrimal gland enlargement with homogeneous contrast enhancement and diffuse mild enlargement of the left lateral and superior rectus muscles. The results of the extended workup for autoimmune and infectious etiologies and the systemic examination findings were normal. Systemic corticosteroids were started for the orbital pseudotumor. The presented case of orbital pseudotumor development after the mRNA vaccine may be considered to be an immunological process targeting the orbital tissue following immunization, although the cause-effect relationship remains uncertain.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - 31(2023), 6 vom: 01. Aug., Seite 1141-1144 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yucel Gencoglu, Aysun [VerfasserIn] |
---|
Links: |
---|
Themen: |
Blepharoptosis |
---|
Anmerkungen: |
Date Completed 23.10.2023 Date Revised 23.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09273948.2022.2093757 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344339351 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344339351 | ||
003 | DE-627 | ||
005 | 20231226022534.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2022.2093757 |2 doi | |
028 | 5 | 2 | |a pubmed24n1147.xml |
035 | |a (DE-627)NLM344339351 | ||
035 | |a (NLM)35914301 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yucel Gencoglu, Aysun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Orbital Inflammatory Pseudotumor following mRNA COVID-19 Vaccination |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.10.2023 | ||
500 | |a Date Revised 23.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The authors present a case of orbital pseudotumor after mRNA COVID-19 vaccination. A 40-year-old otherwise healthy woman was referred to our oculoplastics unit because of left blepharoptosis of 2 months duration starting 1 week after she received her first Pfizer-BioNTech mRNA vaccination. On presentation, her best-corrected visual acuity was 20/20 in each eye. The external examination revealed left blepharoptosis and mild upper eyelid swelling. Orbital magnetic resonance imaging revealed left lacrimal gland enlargement with homogeneous contrast enhancement and diffuse mild enlargement of the left lateral and superior rectus muscles. The results of the extended workup for autoimmune and infectious etiologies and the systemic examination findings were normal. Systemic corticosteroids were started for the orbital pseudotumor. The presented case of orbital pseudotumor development after the mRNA vaccine may be considered to be an immunological process targeting the orbital tissue following immunization, although the cause-effect relationship remains uncertain | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Blepharoptosis | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a idiopathic orbital inflammation | |
650 | 4 | |a mRNA COVID-19 vaccination | |
650 | 4 | |a orbital pseudotumor | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
700 | 1 | |a Mangan, Mehmet Serhat |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g 31(2023), 6 vom: 01. Aug., Seite 1141-1144 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2023 |g number:6 |g day:01 |g month:08 |g pages:1141-1144 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2022.2093757 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2023 |e 6 |b 01 |c 08 |h 1141-1144 |